DNTH103
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for DNTH103, covering 2025-10-06 to 2026-04-21. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE) [Phase 3]